Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.
Due to the COVID-19 pandemic, the global Indocyanine Green market size is estimated to be worth US$ 49 million in 2021 and is forecast to a readjusted size of US$ 68 million by 2028 with a CAGR of 4.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Indocyanine Green market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Indocyanine Green landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Europe is the largest market with about 52% market share. USA and China are follower, accounting for about 33% market share.
The key players are Akorn, PULSION Medical Systems AG, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical Co., Ltd., Aurolab, Yichuang, Eisai etc. Top 3 companies occupied about 60% market share.
This report focuses on Indocyanine Green volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Indocyanine Green market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Indocyanine Green Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Type I
Type II
Segment by Application
Ophthalmology
Neurosurgery
Liver Diseases
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Akorn
PULSION Medical Systems AG
Diagnostic Green
SERB
Daiichi Sankyo Company
Santen Pharmaceutical Co., Ltd.
Aurolab
Yichuang
Eisai
Due to the COVID-19 pandemic, the global Indocyanine Green market size is estimated to be worth US$ 49 million in 2021 and is forecast to a readjusted size of US$ 68 million by 2028 with a CAGR of 4.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Indocyanine Green market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Indocyanine Green landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Europe is the largest market with about 52% market share. USA and China are follower, accounting for about 33% market share.
The key players are Akorn, PULSION Medical Systems AG, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical Co., Ltd., Aurolab, Yichuang, Eisai etc. Top 3 companies occupied about 60% market share.
This report focuses on Indocyanine Green volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Indocyanine Green market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Indocyanine Green Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Type I
Type II
Segment by Application
Ophthalmology
Neurosurgery
Liver Diseases
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Akorn
PULSION Medical Systems AG
Diagnostic Green
SERB
Daiichi Sankyo Company
Santen Pharmaceutical Co., Ltd.
Aurolab
Yichuang
Eisai
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
